alphaRep-HR2 entry inhibitors and a non-antigenic test for the treatment and diagnosis of COVID-19

• Unité de recherche: INNOSUISSE
• Numéro de projet: 54121.1 IP-LS
• Titre du projet anglais: alphaRep-HR2 entry inhibitors and a non-antigenic test for the treatment and diagnosis of COVID-19

Description succincte (Allemand)

alphaRep-HR2 entry inhibitors and a non-antigenic test for the treatment and diagnosis of COVID-19

Description succincte (Anglais)

alphaRep-HR2 entry inhibitors and a non-antigenic test for the treatment and diagnosis of COVID-19

Résumé des résultats (Abstract) (Allemand)

The SARS-CoV2 pandemic is a major health, economic and societal issue worldwide. Despite the advent of vaccines, novel therapeutic and diagnostic options are needed. Here, we wish to use S artificial nanoligands to develop novel potent entry inhibitors and a non-antigenic test for massive screening.